Home » Topics » Regulatory

Regulatory
RSS

FDA clears new Tilade formulation

Nov. 18, 1997

Dainippon develops sustained-release morphine preparation

Nov. 18, 1997

Cardioprotective activity of monoHER demonstrated in preclinical models

Nov. 17, 1997

Roche launches Fortovase in U.S.

Nov. 17, 1997

Anesta's Actiq denied FDA approval

Nov. 17, 1997

Aradigm tests inhalation form of morphine in volunteers

Nov. 14, 1997

New formulation of amiodarone shows favorable hemodynamic effects

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

FDA approves Intron A for non-Hodgkin's lymphoma

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...